Business
Update on Integumen Collaboration
Update on Integumen Collaboration.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 9402Z\n Avacta Group PLC\n 24 September 2020\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 24 September 2020\n \n \n Avacta Group plc\n \n \n (\"Avacta\" or \"the Group\" or \"the Company\")\n \n \n \n \n \n Update on Integumen Collaboration \n \n \n \n \n \n Avacta Group plc (AIM: AVCT), the developer of Affimer\n \n \n ®\n \n \n biotherapeutics and reagents, is pleased to note the update by Integumen plc (AIM: SKIN) (\"Integumen\") provided today regarding their ongoing development of Affimer-based sensors for the coronavirus in waste water and in human breath.\n \n \n \n \n Dr Alastair Smith, Chief Executive of Avacta Group commented:\n \n \n \"I am very pleased to learn of the promising evaluation of the Affimer reagents in Integumen's sensor systems. Once detailed validation of the sensors has been carried out using SARS-COV-2 virus samples at the University of Aberdeen, and we have reviewed those data, Avacta will provide a further update to the market.\"\n \n \n \n - Ends- \n \n \n \n \n \n For further information from Avacta Group plc, please contact: \n \n \n \n \n \n \n Avacta Group plc\n \n \n Alastair Smith, Chief Executive Officer\n \n \n Tony Gardiner, Chief Financial Officer\n \n \n \n \n \n \n \n Tel: +44 (0) 844 414 0452\n \n \n \n \n www.avacta.com\n \n \n \n \n \n \n \n \n \n \n \n \n finnCap Ltd \n \n (Nominated Adviser and Joint Broker)\n \n \n Geoff Nash / Giles Rolls - Corporate Finance\n \n \n Tim Redfern - E\n CM\n \n \n \n \n Tel: +44 (0) 207 220 0500\n \n \n \n \n www.finncap.com\n \n \n \n \n \n \n \n \n \n \n \n \n Zeus Capital Limited \n \n (Joint Broker)\n \n \n John Goold / Rupert Woolfenden - Corporate Broking\n \n \n \n \n \n \n Yellow Jersey PR \n \n (Financial Media and IR)\n \n \n Sarah Hollins \n \n \n Henry Wilkinson\n \n \n \n \n \n \n Zyme Communications \n \n (Trade and Regional Media)\n \n \n Katie Odgaard\n \n \n \n \n \n \n \n Tel: +44 (0)203 829 5000\n \n \n www.zeuscapital.co.uk\n \n \n \n \n \n \n \n \n Tel: +44 (0)203 004 9512\n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n Tel: +44 (0)7787 502 947\n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n...